How I Treat Acute Lymphoblastic Leukemia with Incorporation of Novel Therapies
Description
Upon viewing this session, you will be able to:
• Summarize the efficacy and toxicity of novel immunotherapies in acute lymphoblastic leukemia (ALL)
• Review evidence-based treatment approaches for relapsed ALL
• Implement the optimal management for adult patients with ALL
• Summarize the efficacy and toxicity of novel immunotherapies in acute lymphoblastic leukemia (ALL)
• Review evidence-based treatment approaches for relapsed ALL
• Implement the optimal management for adult patients with ALL
Presenters
- Jae Park, MD, Memorial Sloan Kettering Cancer Center
Pricing
| Member Type | Price |
|---|---|
| List Price | $30.00 |
| Active, International, Emeritus, and Honorary Members | $20.00 |
| Associate, International Associate, Student, and Resident Members | $20.00 |
ASH Meeting on Hematologic Malignancies
Hear the latest developments in clinical care, and get answers to your most challenging patient care questions.
Learn more
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
Copyright © 2021 by American Society of Hematology